| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-07 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-07 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |